CardioMEMS^TM System in the Daily Management of Heart Failure: Review of Current Data and Technique of Implantation

References

• Ambrosy AP, Fonarow GC, Butler J, et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014;63(12):1123–1133.
   PubMed Web of Science ®Google Scholar
• Ritzema J, Troughton R, Melton I, et al. Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure. Circulation. 2010;121(9):1086–1095.
   PubMed Web of Science ®Google Scholar
• Kato M, Stevenson LW, Palardy M, et al. The worst symptom as defined by patients during heart failure hospitalization: implications for response to therapy. J Card Fail. 2012;18(7):524–533.
   PubMed Web of Science ®Google Scholar
• Damman K, van Deursen VM, Navis G, et al. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol. 2009;53(7):582–588.
   PubMed Web of Science ®Google Scholar
• Mangi MA, Rehman H, Rafique M, et al. Ambulatory heart failure monitoring: a systemic review. Cureus. 2017;9(4):e1174.
   PubMed Web of Science ®Google Scholar
• Bohm M, Drexler H, Oswald H, et al. Fluid status telemedicine alerts for heart failure: a randomized controlled trial. Eur Heart J. 2016;37(41):3154–3163.
   PubMed Web of Science ®Google Scholar
• Hindricks G, Taborsky M, Glikson M, et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Lancet. 2014;384(9943):583–590.
   PubMed Web of Science ®Google Scholar
• Morgan JM, Kitt S, Gill J, et al. Remote management of heart failure using implantable electronic devices. Eur Heart J. 2017;38(30):2352–2360.
   PubMed Web of Science ®Google Scholar
• Abraham WT, Adamson PB, Bourge RC, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011;377(9766):658–666.
   PubMed Web of Science ®Google Scholar
• Abraham WT, Stevenson LW, Bourge RC, et al. Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial. Lancet. 2016;387(10017):453–461.
   PubMed Web of Science ®Google Scholar
• Adamson PB. Pathophysiology of the transition from chronic compensated and acute decompensated heart failure: new insights from continuous monitoring devices. Curr Heart Fail Rep. 2009;6(4):287–292.
   PubMedGoogle Scholar
• Klein L. (Re)Discovering the Neurohormonal and Hemodynamic Duality of Heart Failure. J Am Coll Cardiol. 2017;70(15):1887–1889.
   PubMed Web of Science ®Google Scholar
• Zile MR, Bennett TD, El Hajj S, et al. Intracardiac pressures measured using an implantable hemodynamic monitor: relationship to mortality in patients with chronic heart failure. Circulation: Heart Failure. 2017;10(1):1.
   Web of Science ®Google Scholar
• Benza RL, Raina A, Abraham WT, et al. Pulmonary hypertension related to left heart disease: insight from a wireless implantable hemodynamic monitor. J heart lung transplant: Offl publ Int Soc Heart Transplant. 2015;34(3):329–337.
   PubMed Web of Science ®Google Scholar
• Heywood JT, Jermyn R, Shavelle D, et al. Impact of practice-based management of pulmonary artery pressures in 2000 patients implanted with the cardioMEMS sensor. Circulation. 2017;135(16):1509–1517.
   PubMed Web of Science ®Google Scholar
• Givertz MM, Stevenson LW, Costanzo MR, et al. Pulmonary artery pressure-guided management of patients with heart failure and reduced ejection fraction. J Am Coll Cardiol. 2017;70(15): 1875–1886.
   PubMed Web of Science ®Google Scholar
• Abraham J, Bharmi R, Jonsson O, et al. Association of ambulatory hemodynamic monitoring of heart failure with clinical outcomes in a concurrent matched cohort analysis. JAMA Cardiol. 2019;4(6): 556–563.
   PubMed Web of Science ®Google Scholar
• Raina A, Abraham WT, Adamson PB, et al. Limitations of right heart catheterization in the diagnosis and risk stratification of patients with pulmonary hypertension related to left heart disease: insights from a wireless pulmonary artery pressure monitoring system. J heart lung transplant: Offl publ Int Soc Heart Transplant. 2015;34(3): 438–447.
   PubMed Web of Science ®Google Scholar
• Desai AS, Bhimaraj A, Bharmi R, et al. Ambulatory hemodynamic monitoring reduces heart failure hospitalizations in “real-world” clinical practice. J Am Coll Cardiol. 2017;69(19):2357–2365.
   PubMed Web of Science ®Google Scholar
• Sandhu AT, Goldhaber-Fiebert JD, Owens DK, et al. Cost-effectiveness of implantable pulmonary artery pressure monitoring in chronic heart failure. JACC: Heart Failure. 2016;4(5):368–375.
   PubMed Web of Science ®Google Scholar
• Raval NY, Shavelle D, Bourge RC, et al. Significant reductions in heart failure hospitalizations with the pulmonary artery pressure guided HF system: preliminary observations from the cardioMEMS post approval study. J Card Fail. 2017;23(8):S27.
   Web of Science ®Google Scholar
• Shavelle DM, Desai AS, Abraham WT Pulmonary artery pressure-guided therapy for ambulatory heart failure patients in clinical practice: 1-year outcomes from the CardioMEMS post-approval study. Presented at: ACC 2019. Mar 17. New Orleans, LA.
   Google Scholar
• Adamson PB, Abraham WT, Bourge RC, et al. Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction. Circulation: Heart Failure. 2014;7(6):935–944.
   PubMed Web of Science ®Google Scholar
• Adamson PB, Abraham WT, Stevenson LW, et al. Pulmonary artery pressure-guided heart failure management reduces 30-day readmissions. Circ Heart Fail. 2016;9(6):6.
   Web of Science ®Google Scholar
• Jermyn R, Alam A, Kvasic J, et al. Hemodynamic-guided heart-failure management using a wireless implantable sensor: infrastructure, methods, and results in a community heart failure disease-management program. Clin Cardiol. 2017;40(3):170–176.
   PubMed Web of Science ®Google Scholar
• Assaad M, Singh R, Sarsam S, et al. Impact of CardioMEMS device placement on lifestyle modifications: a “pseudo-placebo” effect beyond the expected? J Int Med Res. 2018;46(8):3195–3199.
   PubMed Web of Science ®Google Scholar
• Assaad M, Sarsam S, Naqvi A, et al. CardioMems® device implantation reduces repeat hospitalizations in heart failure patients: A single center experience. JRSM Cardiovasc Dis. 2019 Feb 24;8:2048004019833290.
   Web of Science ®Google Scholar
• Yancy CW, Jessup M, Bozkurt B, et al. ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the american college of cardiology/american heart association task force on clinical practice guidelines and the heart failure society of America. J Am Coll Cardiol. 2017;70(6):776–803.
   PubMed Web of Science ®Google Scholar
• Hershberger RE, Nauman D, Walker TL, et al. Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure. J Card Fail. 2003;9(3):180–187.
   PubMed Web of Science ®Google Scholar
• Rogers JG, Butler J, Lansman SL, et al. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. J Am Coll Cardiol. 2007;50(8):741–747.
   PubMed Web of Science ®Google Scholar
• Mancini D, Lietz K. Selection of cardiac transplantation candidates in 2010. Circulation. 2010;122(2):173–183.
   PubMed Web of Science ®Google Scholar
• Miller LW, Guglin M. Patient selection for ventricular assist devices: a moving target. J Am Coll Cardiol. 2013;61(12):1209–1221.
   PubMed Web of Science ®Google Scholar
• Kirklin JK, Naftel DC, Pagani FD, et al. Seventh INTERMACS annual report: 15,000 patients and counting. J heart lung transplant: Offl publ Int Soc Heart Transplant. 2015;34(12):1495–1504.
   PubMed Web of Science ®Google Scholar
• Feldman D, Naka Y, Cabuay B, et al. 241 A wireless hemodynamic pressure sensor before and after ventricular assist device placement: a sub-study of the CHAMPION trial. J Heart Lung Transplant. 2011;30(4):S86.
   PubMed Web of Science ®Google Scholar
• Yandrapalli S, Raza A, Tariq S, et al. Ambulatory pulmonary artery pressure monitoring in advanced heart failure patients. World J Cardiol. 2017;9(1):21–26.
   PubMed Web of Science ®Google Scholar
• Hubbert L, Baranowski J, Delshad B, et al. Left atrial pressure monitoring with an implantable wireless pressure sensor after implantation of a left ventricular assist device. Asaio J. 2017;63(5):e60–e65.
   PubMed Web of Science ®Google Scholar
• Kilic A, Katz JN, Joseph SM, et al. Changes in pulmonary artery pressure before and after left ventricular assist device implantation in patients utilizing remote haemodynamic monitoring. ESC Heart Fail. 2019;6(1):138–145.
   PubMed Web of Science ®Google Scholar
• Angermann CE, Assmus B, Anker SD, et al. Safety and feasibility of pulmonary artery pressure-guided heart failure therapy: rationale and design of the prospective cardioMEMS monitoring study for heart failure (MEMS-HF). Clin Res Cardiol. 2018;107(11):991–1002.
   PubMed Web of Science ®Google Scholar
• Binanay C, Califf RM, Hasselblad V, et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. Jama. 2005;294(13):1625–1633.
   PubMed Web of Science ®Google Scholar
• Hoeper MM, Lee SH, Voswinckel R, et al. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol. 2006;48(12):2546–2552.
   PubMed Web of Science ®Google Scholar
• Vaduganathan M, DeFilippis EM, Fonarow GC, et al. Postmarketing adverse events related to the cardioMEMS HF system. JAMA Cardiol. 2017;2(11):1277–1279.
   PubMed Web of Science ®Google Scholar
• MAUDE: Manufacturer and user facility device experience. [cited 2017 Aug 25]. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUDE/search.CFM.
   Google Scholar
• Veenis JF, Manintveld OC, Constantinescu AA, et al. Design and rationale of haemodynamic guidance with CardioMEMS in patients with a left ventricular assist device: the HEMO-VAD pilot study. ESC Heart Fail. 2019;6(1):194–201.
   PubMed Web of Science ®Google Scholar
• Lindenfeld J, Abraham WT, Maisel A, et al. Hemodynamic-GUIDEd management of Heart Failure (GUIDE-HF). Am Heart J. 2019;214:18–27.
   PubMed Web of Science ®Google Scholar
• Olshansky B, Richards M, Sharma A, et al. Survival after rate-responsive programming in patients with cardiac resynchronization therapy-defibrillator implants is associated with a novel parameter: the heart rate score. Circ Arrhythm Electrophysiol. 2016;9:8.
   Web of Science ®Google Scholar
• Bourge RC, Abraham WT, Adamson PB, et al. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol. 2008;51(11):1073–1079.
   PubMed Web of Science ®Google Scholar
• Abraham WT, Adamson PB, Costanzo MR, et al. Hemodynamic monitoring in advanced heart failure: results from the LAPTOP-HF trial. J Card Fail. 2016;22(11):940.
   Web of Science ®Google Scholar
• Abraham WT, Perl L. Implantable hemodynamic monitoring for heart failure patients. J Am Coll Cardiol. 2017;70(3):389–398.
   PubMed Web of Science ®Google Scholar
• Verdejo HE, Castro PF, Concepcion R, et al. Comparison of a radiofrequency-based wireless pressure sensor to swan-ganz catheter and echocardiography for ambulatory assessment of pulmonary artery pressure in heart failure. J Am Coll Cardiol. 2007;50(25):2375–2382.
   PubMed Web of Science ®Google Scholar
• Tolia S, Khan Z, Gholkar G, et al. Validating left ventricular filling pressure measurements in patients with congestive heart failure: cardiomems™ pulmonary arterial diastolic pressure versus left atrial pressure measurement by transthoracic echocardiography. Cardiol Res Pract. 2018;2018:8568356.
   PubMed Web of Science ®Google Scholar
• Abraham J, McCann P, Wang L, et al. Internal jugular vein as alternative access for implantation of a wireless pulmonary artery pressure sensor. Circulation: Heart Failure. 2019;12(8): e006060.
   PubMed Web of Science ®Google Scholar
• Dasa O, Shafiq Q, Ruzieh M, et al. Patient factors but not the use of novel anticoagulants or warfarin are associated with internal jugular vein access-site hematoma after right heart catheterization. J Invasive Cardiol. 2017;29(12):401–403.
   PubMed Web of Science ®Google Scholar
• Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347(18):1397–1402.
   PubMed Web of Science ®Google Scholar
• Chen J, Ross JS, Carlson MD, et al. Skilled nursing facility referral and hospital readmission rates after heart failure or myocardial infarction. Am J Med. 2012;125(1):100.e101-109.
   Web of Science ®Google Scholar
• Nieminen MS, Dickstein K, Fonseca C, et al. The patient perspective: quality of life in advanced heart failure with frequent hospitalisations. Int J Cardiol. 2015;191:256–264.
   PubMed Web of Science ®Google Scholar
• Stromberg A, Luttik ML. Burden of caring: risks and consequences imposed on caregivers of those living and dying with advanced heart failure. Curr Opin Support Palliat Care. 2015;9(1):26–30.
   PubMed Web of Science ®Google Scholar
• Heidenreich PA, Albert NM, Allen LA, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circulation: Heart Failure. 2013;6(3):606–619.
   PubMed Web of Science ®Google Scholar
• Schmier JK, Ong KL, Fonarow GC. Cost-effectiveness of remote cardiac monitoring with the cardioMEMS heart failure system. Clin Cardiol. 2017;40(7):430–436.
   PubMed Web of Science ®Google Scholar
• Martinson M, Bharmi R, Dalal N, et al. Pulmonary artery pressure-guided heart failure management: US cost-effectiveness analyses using the results of the CHAMPION clinical trial. Eur J Heart Fail. 2017;19(5):652–660.
   PubMed Web of Science ®Google Scholar
• Cowie MR, Simon M, Klein L, et al. The cost-effectiveness of real-time pulmonary artery pressure monitoring in heart failure patients: a European perspective. Eur J Heart Fail. 2017;19(5):661–669.
   PubMed Web of Science ®Google Scholar
• Anderson JL, Heidenreich PA, Barnett PG, et al. ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American college of cardiology/American Heart association task force on performance measures and task force on practice guidelines. J Am Coll Cardiol. 2014;63(21):2304–2322.
   PubMed Web of Science ®Google Scholar
• CardioMEMSTM HF system user’s manual. [cited 2018 Apr 24]. https://www.accessdata.fda.gov/cdrh_docs/pdf10/p100045d.pdf
   Google Scholar
• “AliveCor data yield reaches 25MM ECGs largest data set of any consumer ECG. Device.” AliveCor Press Release, 5 Apr. 2018, www.alivecor.com/press/press_release/alivecor-data-yield-reaches-25mm-ecgs/
   Google Scholar